Andere talen Biogen Inc. Sao Paulo

Aandelen

BIIB34

BRBIIBBDR001

Vertraagde tijd Sao Paulo Andere beurzen 20:05:44 03-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
211,9 ^BRL	-1,43%		-1,43%	+3,25%

02/07	Amerikaanse aandelenmarkten eindigen dinsdag hoger na commentaar Fed-voorzitter Powell	MT
02/07	Aandelenmarkten overwegend hoger intraday na commentaar Fed-voorzitter Powell	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen	15:41
July 22, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against BIIB	11:46
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit	05:01
US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments	02/07
Equity Markets Mostly Rise Intraday After Fed Chair Powell's Comments	02/07
Eli Lilly Alzheimer's drug approved by US FDA	02/07
Biogen Inc. Sued for Securities Law Violations - Contact the Schall Law Firm to Discuss Your Legal Rights BIIB	02/07
Biogen Closes Human Immunology Biosciences Acquisition	02/07
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB	02/07
Biogen Completes Acquisition of Human Immunology Biosciences	02/07
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc.(BIIB) Shareholders	01/07
Japan's Eisai developing dementia drug for US market, Nikkei reports	30/06
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Biogen Inc. (BIIB)	29/06
BIIB LAWSUIT ALERT: The Gross Law Firm Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	28/06
Biogen, Eisai Launch Leqembi in China to Treat Alzheimer's Disease	28/06
Eisai and Biogen launch Alzheimer's drug Leqembi in China	28/06
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China	28/06
Eisai Co., Ltd. and Biogen Inc. Announces Launch of Leqembi in China	28/06
Immunome, Inc. Appoints Phil Tsai as Chief Technical Officer	27/06
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit	26/06

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biogen Inc. Sao Paulo

Aandelen

BIIB34

BRBIIBBDR001

Andere talen

Filters